Private Equity

The Commission's Target Strategic Asset Allocation includes an 10% allocation to private equity.

Please click here for information on Innovation Fund - Ireland.

NPRF Private Equity Portfolio as at 31 December 2011


Year
Investment
Region

2005 CVC European Equity Partners Fund IV Europe
2005 Vestar Capital Partners Fund V US/Europe
2005 Clayton, Dubilier & Rice Fund VII US/Europe
2006 Greenspring Associates III US
2006 Charterhouse Capital Partners Fund VIII Europe
2006 Madison Dearborn Capital Partners V US
2006 Fortress Investment Fund IV US/Europe
2006 Fortress Investment Fund IV
Co-investment Fund
US/Europe
2006 Oak Investment Partners XII US
2006 Texas Pacific Group Fund V Global
2006 Palamon European Equity II Europe
2006 Intrawest (Fortress Co-investment) US
2006 Providence Equity Partners VI US/Europe
2006 Clayton, Dubilier and Rice VII
Co-investment Fund
US/Europe
2006 Abingworth Bioventures V US/Europe
2006 Hellman & Friedman VI US/Europe
2007 Fortress Investment Fund V US/Europe
2007 Fortress Investment Fund V
Co-Investment Fund
US/Europe
2007 Weathergage I US
2007 Delta Equity Fund III Ireland
2007 New Mountain Partners III US
2007 Jordan Resolute II US
2007 Frazier Healthcare VI US
2008 Nordic Capital Fund VII Europe
2008 Oaktree Capital Management Opportunities VIIb US/Europe
2008 Fountain Healthcare I Ireland
2008 Greenspring Associates IV Global
2008 Summit Partners Europe Europe
2008 Summit Subordinated Debt Fund IV US/Europe
2008 Abingworth Bioventures V Co-investment Fund US/Europe
2008 CVC European Equity Partners Fund V Global
2008 Clayton, Dubilier & Rice Fund VIII US/Europe
2008 Texas Pacific Group Fund VI Global
2008 Charterhouse Capital Partners Fund IX Europe
2008 Ulster Bank Diageo Venture Fund Ireland
2008 Seroba Kernel Life Sciences Fund II Ireland
2010 HIG Bayside Loan Opportunity Fund II US/Europe
2010 Atlantic Bridge II Europe
2010 Draper Fisher Jurvetson Fund X Global
2010 DFJ Esprit Fund III Europe
2010 Polaris Venture Partners Fund VI Global